Search

Introduction: Angiogenesis, the formation of new capillaries from pre-existing vessels, crucially involves activation of the hypoxia-inducible factor 1 (HIF-1) and vascular endothelial growth factor (VEGF) genes. This study investigates the impact of exercise intensity on the expression of angiogenic genes in the hearts of male rats. Material & Methods: Eighteen male Wistar rats were randomly assigned to three groups: High-Intensity Interval Training (HIIT), Continuous Training (CT), and control (C). Both HIIT and CT groups underwent 8 weeks of training with five sessions per week. Anesthesia and blood sampling occurred 48 hours post final training session. Gene levels of HIF-1 and VEGF were measured in the left ventricle. Data analysis employed ANOVA and LSD post hoc tests (P=0.05). Results: VEGF gene expression significantly increased in both HIIT and CT groups compared to the control group (P = 0.001), with a more pronounced elevation in the HIIT group than the CT group (P = 0.004). Furthermore, HIF-1 levels exhibited a significant reduction in both HIIT (P = 0.001) and CT (P = 0.001) groups compared to the control group, with the HIIT-induced decrease surpassing that of the CT group (P = 0.049). Conclusion: The noteworthy elevation in VEGF and decrease in HIF-1 gene expression levels in trained rats imply that exercise training enhances angiogenesis. Importantly, the extent of this enhancement is contingent upon exercise intensity, with HIIT demonstrating more pronounced positive effects on VEGF levels. [ABSTRACT FROM AUTHOR]

Effective interfacial engineering to fabricate a suitable nano-photocatalyst for environmental remediation is on high demand. A magnetic nanocomposite is a potential candidate for reusability and recovery from treated wastewater. CuFe2O4/CdS nanoclusters (NCs) were fabricated using a chemical co-precipitation method. SEM and TEM images of the fabricated NCs revealed coral-like agglomerations and polycrystalline nature of NCs with clear lattice fringes. XPS and EDAX were performed for elemental analysis. The apparent photodegradation rate of dye by NCs is two-fold higher compared to that of pure CdS and CuFe2O4. The S-scheme interface retained both strong potential e−/h+ for ˙OH and ˙O2− production under visible light illumination. A 97.71% photocatalytic efficiency was retained after six cycles of reuse. This enhancement in the photocatalytic performance of NCs demonstrates their excellent potential to behave as environmental remediating agents. [ABSTRACT FROM AUTHOR]

Currently, polymer organic solar cells (POSCs) are widely utilized due to their significant application, such as low-cost power conversion efficiencies (PCEs). Therefore, we designed a series of photovoltaic materials (D1, D2, D3, D5 and D7) by the incorporation of selenophene units (n = 1–7) as π1-spacers by considering the importance of POSCs. Density functional theory (DFT) calculations were accomplished at MPW1PW91/6-311G (d, p) functional to explore the impact of additional selenophene units on the photovoltaic behavior of the above-mentioned compounds. A comparative analysis was conducted for designed compounds and reference compounds (D1). Reduction in energy gaps (∆E = 2.399 − 2.064 eV) with broader absorption wavelength (λmax = 655.480 − 728.376 nm) in chloroform along with larger charge transference rate was studied with the addition of selenophene units as compared to D1. A significantly higher exciton dissociation rate was studied as lower values of binding energy (Eb = 0.508 − 0.362 eV) were noted in derivatives than in the reference (Eb = 0.526 eV). Moreover, transition density matrix (TDM) and density of state (DOS) data also supported the efficient charge transition origination from HOMOs to LUMOs. Open circuit voltage (Voc) was also calculated for all the aforesaid compounds to check the efficiency, and significant results were seen (1.633–1.549 V). All the analyses supported our compounds as efficient POSCs materials with significant efficacy. These compounds might encourage the experimental researchers to synthesize them due to proficient photovoltaic materials. [ABSTRACT FROM AUTHOR]

A set of novel N-methylspiropyrrolidine hybrids have been synthesized regio selectively employing 1,3-dipolar cycloaddition reaction of substituted chalcones with azomethine ylides (work up in situ from isatin and sarcosine). The spiropyrrolidines structures were studied using FT-IR, 1H and 13C NMR spectroscopic data, and was finally confirmed by X-ray diffraction study. Hirshfeld surface analysis was correlated with X-ray diffraction and described different intermolecular contacts. Good antibacterial activity was reported against gram-positive and gram-negative bacterial strains of Bacillus subtillis, Enterococcus faecalis, E. coli, and Pseudomonas aeruginosa. Initially, antibacterial activity of compounds was confirmed by the zone of inhibition. Most of the compounds have shown MIC and MBC in the range between 50-200 µg∕mL against both types of bacteria. Further, for mechanism of action, the tested compounds were checked for the inhibition of an established bacterial drug target, DNA gyrase using in silico approaches. [ABSTRACT FROM AUTHOR]

Ruthenium complexes are considered as the most favorable alternatives to traditional platinum-based cancer drugs owing to their acceptable toxicity level, selectivity, variant oxidation states and ability to treat platinum-resistant cancer cells. They have similar ligand exchange kinetics as platinum drugs but can be tailored according to our desire by ligands influence. In the current study, we illustrate the in-vitro anticancer profile of some ruthenium complexes (2016–2021) against human hepatocellular carcinoma (HepG2). The anticancer activity of ruthenium complexes is determined by comparing their IC50 values with one another and positive controls. Fortunately, some ruthenium complexes including 3, 4, 6, 14, 15, 20, 42, and 48 exhibit surpassed in-vitro anticancer profile than that of positive controls promising as potential candidates against liver cancer. We also explored the structure-activity relationship (SAR) which is a key factor in the rational designing and synthesis of new ruthenium drugs. It covers the factors affecting anticancer activity including lipophilicity, planarity, area and bulkiness, the steric influence of different ligands, and electronic effects induced by ligands, stability, aqueous solubility and bioavailability to the target sites. The data reported here will provide strong support in the plausible design and synthesis of ruthenium anticancer drugs in the upcoming days. [ABSTRACT FROM AUTHOR]

Background: Anti‐programmed death‐1 (PD‐1) immunotherapy has drastically improved survival for metastatic melanoma; however, 50% of patients have progression within 6 months despite treatment. In this study, we investigated host, and tumor factors for metastatic melanoma patients treated with anti‐PD‐1 immunotherapy. Methods: Patients treated with the anti‐PD‐1 immunotherapy between 2014 and 2017 were identified in Alberta, Canada. All patients had Stage IV melanoma. Patient characteristics, investigations, treatment, and clinical outcomes were obtained from electronic medical records. Results: We identified 174 patients treated with anti‐PD‐1 immunotherapy. At 37.1 months median follow‐up time 135 (77.6%) individuals had died and 150 (86.2%) had progressed. An elevated lactate dehydrogenase (LDH) had a response rate of 21.0% versus 41.0% for those with a normal LDH (p = 0.017). Host factors associated with worse median progression‐free survival (mPFS) and median overall survival (mOS) included liver metastases, >3 sites of disease, elevated LDH, thrombocytosis, neutrophilia, anemia, lymphocytopenia, and an elevated neutrophil/lymphocyte ratio. Primary ulcerated tumors had a worse mOS of 11.8 versus 19.3 months (p = 0.042). We identified four prognostic subgroups in advanced melanoma patients treated with anti‐PD‐1 therapy. (1) Normal LDH with <3 visceral sites, (2) normal LDH with ≥3 visceral sites, (3) LDH 1‐2x upper limit of normal (ULN), (4) LDH ≥2x ULN. The mPFS each group was 14.0, 6.5, 3.3, and 1.9 months, while the mOS for each group was 33.3, 15.7, 7.9, and 3.4 months. Conclusion: Our study reports that host factors measuring the general immune function, markers of systemic inflammation, and tumor burden and location are the most prognostic for survival. [ABSTRACT FROM AUTHOR]